A Descriptive Pharmaco-epidemiological Study of a Hypertensive Patient Population Treated With a Fixed-dose Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg and of Conditions for the Management of Arterial Hypertension
A Descriptive Pharmaco-epidemiological Study of a Hypertensive Patient Population Treated With a Fixed-dose Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg and of Conditions for the Management of Arterial Hypertension
It is a national, retrospective , observational study in hypertensive patients treated for at least 8 weeks with the fixed dose combination of telmisartan 80 mg and hydrochlorothiazide 25 mg. The primary objective is to assess the control rate (systolic and diastolic blood pressure). Key secondary objectives are to assess the blood pressure reduction after at least 8 weeks of treatment, describe the population treated with this new fixed dose combination
Inclusion criteria:
Exclusion criteria:
- Treated with the combination less than 8 weeks
Bleriot, France
Callac de Bretagne, France
Callac de Bretagne, France
Chateauneuf Ille Vilaine, France
Conflans Ste Honorine, France
Conflans Ste Honorine, France
Le Golfe Juan, France
Moncontour de Bretagne, France
Saint Maximin La Ste Baume, France
Saint Rene Hillion, France
Ste Cecile, France
Ste Fereole, France
Ste Hermine, France
Ste Mere Eglise, France
Ste Savine, France
Terrasson La Villedieu, France